37 research outputs found
Experience-based co-design - Adapting the method for a researcher-initiated study in a multi-site setting
YesBackground: Experience-based co-design (EBCD) brings patients and staff together to co-design services. It is normally conducted in one organization which initiates and implements the process. We used the traditional EBCD method with a number of adaptations as part of a larger research study in the British National Health Service.Methods: The primary aim was to assess the feasibility and acceptability of conduct-ing research-initiated EBCD, to enhance intervention development prior to testing. As well as embedding the method in a research study, there were 3 further key adap-tations: (a) working across primary and secondary care sectors, (b) working on multi-ple sites and (c) incorporating theory-informed analysis.Results: We recruited four sites (covering both primary and secondary care) and, on each site, conducted the initial traditional EBCD meetings, with separate staff and patient groupsāfollowed by a single joint patient-staff event, where four priority areas for co-design were agreed. This event was driven by theory-informed analysis, as well as the traditional trigger film of patient experiences. Each site worked on one priority area, and the four co-design groups met over 2-3 months to design prototype tools. A second joint event was held (not usually undertaken in single-site EBCD) where they shared and compared outputs. The research team combined elements of these outputs to create an intervention, now being tested in a cluster randomized controlled trial.Conclusions: EBCD can be successfully adapted for use across an entire patient pathway with multiple organizations and as part of a research process to identify an intervention for subsequent testing in a randomized trial. Our pragmatic approach used the patient experience to identify areas for improvement and co-designed an intervention which directly reflected patient priorities.National Institute for Health Research programme āImproving the safety and continuity of medicines management at care transitions (ISCOMAT)ā RPāPGā0514ā2009
Recommended from our members
Successful care transitions for older people: a systematic review and meta-analysis of the effects of interventions that support medication continuity
YesBackground: medication-related problems occur frequently when older patients are discharged from hospital. Interventions
to support medication use have been developed; however, their effectiveness in older populations are unknown. This review
evaluates interventions that support successful transitions of care through enhanced medication continuity.
Methods: a database search for randomised controlled trials was conducted. Selection criteria included mean participant age
of 65 years and older, intervention delivered during hospital stay or following recent discharge and including activities that
support medication continuity. Primary outcome of interest was hospital readmission. Secondary outcomes related to the safe
use of medication and quality of life. Outcomes were pooled by random-effects meta-analysis where possible.
Results: twenty-four studies (total participants=17,664) describing activities delivered at multiple time points were included.
Interventions that bridged the transition for up to 90 days were more likely to support successful transitions. The meta-analysis,
stratified by intervention component, demonstrated that self-management activities (RR 0.81 [0.74, 0.89]), telephone followup
(RR 0.84 [0.73, 0.97]) and medication reconciliation (RR 0.88 [0.81, 0.96]) were statistically associated with reduced
hospital readmissions.
Conclusion: our results suggest that interventions that best support older patientsā medication continuity are those that
bridge transitions; these also have the greatest impact on reducing hospital readmission. Interventions that included self management,
telephone follow-up and medication reconciliation activities were most likely to be effective; however, further
research needs to identify how to meaningfully engage with patients and caregivers to best support post-discharge medication
continuity. Limitations included high subjectivity of intervention coding, study heterogeneity and resource restrictions.National Institute for Health Research (NIHR) under its Research for Patient Benefit (RfPB) Programme (Grant PB-PG-0317-20010)
Recommended from our members
How effective are primary care pharmacists at running dyspepsia clinics for patients prescribed PPIs?
YesIntroduction
As a consequence of the low cost and perceived safety, proton pump inhibitors (PPIs) are widely prescribed but they can cause longterm adverse effects and are often overprescribed. For most patients PPIs should not be continued long-term as patients can become dependent on PPIs and they are rarely stepped down/off treatment. We aimed to measure whether a dyspepsia review service could help patients on PPIs to step down/off treatment whilst still keeping them symptom free.
Methods
Pharmacists were provided with training on dyspepsia management. Four general practices were selected. Patients taking a PPI for more than two months were included. A list of exclusion criteria (e.g. active ulcers, newly initiated) was applied. Between six and eight dyspepsia review clinics were run at each site. Patients were booked into a 15-minute consultation. A concordance style consultation was held with clinicians providing information on dyspepsia management and exploring the patientsā ideas, concerns and expectations about stepping down or stepping off treatment. A follow-up audit was performed at four months to determine if patients had remained stepped down/off. An economic evaluation of clinic costs and drugs savings was performed.
Results
A total of 508 patients were invited to a review; 136 did not attend and 58 were excluded due to not meeting the inclusion criteria, leaving
314 patients reviewed for step-down/step-off. Successful step down/step off was achieved in 257 people (82% of those reviewed). The total cost savings of PPIs was Ā£7,100. The additional cost of alginates was Ā£1,207 giving a net saving on medicines of Ā£5,893 per annum. Set-up costs were Ā£1,194 and staff costs Ā£3,524 to Ā£5,156 giving total running costs, which vary dependent on the Agenda for Change (AfC) grade of pharmacist involved, of Ā£4,720 - Ā£6,351.
Conclusion
A dyspepsia review clinic is cost-neutral to run but, given that many patients are on polypharmacy, PPI step down might best be
considered as part of a holistic medication review clinic.Reckitt Benckiser, National Institute for Health Research, Health Education Englan
Supporting medicines management for older people at care transitions ā a theory-based analysis of a systematic review of 24 interventions
Abstract: Background: Older patients are at severe risk of harm from medicines following a hospital to home transition. Interventions aiming to support successful care transitions by improving medicines management have been implemented. This study aimed to explore which behavioural constructs have previously been targeted by interventions, which individual behaviour change techniques have been included, and which are yet to be trialled. Method: This study mapped the behaviour change techniques used in 24 randomised controlled trials to the Behaviour Change Technique Taxonomy. Once elicited, techniques were further mapped to the Theoretical Domains Framework to explore which determinants of behaviour change had been targeted, and what gaps, if any existed. Results: Common behaviour change techniques used were: goals and planning; feedback and monitoring; social support; instruction on behaviour performance; and prompts/cues. These may be valuable when combined in a complex intervention. Interventions mostly mapped to between eight and 10 domains of the Theoretical Domains Framework. Environmental context and resources was an underrepresented domain, which should be considered within future interventions. Conclusion: This study has identified behaviour change techniques that could be valuable when combined within a complex intervention aiming to support post-discharge medicines management for older people. Whilst many interventions mapped to eight or more determinants of behaviour change, as identified within the Theoretical Domains Framework, careful assessment of the barriers to behaviour change should be conducted prior to intervention design to ensure all appropriate domains are targeted
Recommended from our members
A Grounded Theory approach to understanding the role of medication safety within a hospital early discharge team
YesConference abstract from the British Geriatrics Society Autumn Meeting, 14-16 Nov 2018, London, UK
Post-discharge medicines management: the experiences, perceptions and roles of older people and their family carers
YesMultiple changes are made to older patients' medicines during hospital admission, which can sometimes cause confusion and anxiety. This results in problems with post-discharge medicines management, for example medicines taken incorrectly, which can lead to harm, hospital readmission and reduced quality of life.
To explore the experiences of older patients and their family carers as they enacted post-discharge medicines management.
Semi-structured interviews took place in participants' homes, approximately two weeks after hospital discharge. Data analysis used the Framework method.
Recruitment took place during admission to one of two large teaching hospitals in North England. Twenty-seven participants aged 75 plus who lived with long-term conditions and polypharmacy, and nine family carers, were interviewed.
Three core themes emerged: impact of the transition, safety strategies and medicines management role. Conversations between participants and health-care professionals about medicines changes often lacked detail, which disrupted some participants' knowledge and medicines management capabilities. Participants used multiple strategies to support post-discharge medicines management, such as creating administration checklists, seeking advice or supporting primary care through prompts to ensure medicines were supplied on time. The level to which they engaged with these activities varied.
Participants experienced gaps in their post-discharge medicines management, which they had to bridge through implementing their own strategies or by enlisting support from others. Areas for improvement were identified, mainly through better communication about medicines changes and wider involvement of patients and family carers in their medicines-related care during the hospital-to-home transition.This work was supported by the National Institute for Health Research (NIHR) Yorkshire and Humber Patient Safety Translational Research Centre (NIHR Yorkshire and Humber PSTRC). This independent research is funded by the National Institute for Health Research (NIHR) under its Research for Patient Benefit (RfPB) Programme (Grant Reference Number PB-PG-0317-20010)
Can we improve recruitment to trials and informed consent by improving participant information sheets? - A nested RCT
Recommended from our members
Improving the quality of insulin prescribing for people with diabetes being discharged from hospital
YesMedication errors involving insulin in hospital are common,
and may be particularly problematic at the point of transfer
of care. Our aim was to improve the safety of insulin
prescribing on discharge from hospital using a continuous
improvement methodology involving cycles of iterative
change. A multidisciplinary project team formulated
locally tailored insulin discharge prescribing guidance.
After baseline data collection, three āplan-do-study-actā
cycles were undertaken over a 3-week period (September/
October 2018) to introduce the guidelines and improve the
quality of discharge prescriptions from one diabetes ward
at the hospital. Discharge prescriptions involving insulin
from the ward during Monday to Friday of each week were
examined, and their adherence to the guidance measured.
After the introduction of the guidelines in the form of a
poster, and later a checklist, the adherence to guidelines
rose from an average of 50% to 99%. Qualitative data
suggested that although it took pharmacists slightly longer
to clinically verify discharge prescriptions, the interventions
resulted in a clear and helpful reminder to help improve
discharge quality for the benefit of patient safety. This
project highlights that small iterative changes made by a
multidisciplinary project team can result in improvement
of insulin discharge prescription quality. The sustainability
and scale of the intervention may be improved by its
integration into the electronic prescribing system so that
all users may access and refer to the guidance when
prescribing insulin for patients at the point of discharge
Recommended from our members
Co-designing an intervention to improve the process of deprescribing for older people living with frailty in the United Kingdom
BACKGROUND: In older people living with frailty, polypharmacy can lead to preventable harm like adverse drug reactions and hospitalization. Deprescribing is a strategy to reduce problematic polypharmacy. All stakeholders should be actively involved in developing a person-centred deprescribing process that involves shared decision-making. OBJECTIVE: To co-design an intervention, supported by a logic model, to increase the engagement of older people living with frailty in the process of deprescribing. DESIGN: Experience-based co-design is an approach to service improvement, which uses service users and providers to identify problems and design solutions. This was used to create a person-centred intervention with the potential to improve the quality and outcomes of the deprescribing process. A 'trigger film' showing older people talking about their healthcare experiences was created and facilitated discussions about current problems in the deprescribing process. Problems were then prioritized and appropriate solutions were developed. The review located the solutions in the context of current processes and procedures. An ideal care pathway and a complex intervention to deliver better care were developed. SETTING AND PARTICIPANTS: Older people living with frailty, their informal carers and professionals living and/or working in West Yorkshire, England, UK. Deprescribing was considered in the context of primary care. RESULTS: The current deprescribing process differed from an ideal pathway. A complex intervention containing seven elements was required to move towards the ideal pathway. Three of these elements were prototyped and four still need development. The complex intervention responded to priorities about (a) clarity for older people about what was happening at all stages in the deprescribing process and (b) the quality of one-to-one consultations. CONCLUSIONS: Priorities for improving the current deprescribing process were successfully identified. Solutions were developed and structured as a complex intervention. Further work is underway to (a) complete the prototyping of the intervention and (b) conduct feasibility testing. PATIENT OR PUBLIC CONTRIBUTION: Older people living with frailty (and their informal carers) have made a central contribution, as collaborators, to ensure that a complex intervention has the greatest possible potential to enhance the experience of deprescribing medicines
Can user testing of a clinical trial patient information sheet make it fit-for-purpose? - a randomized controlled trial
Background:
The participant information sheet (PIS) provided to potential trial participants is a critical part of the process of valid consent. However, there is long-standing concern that these lengthy and complex documents are not fit-for-purpose. This has been supported recently through the application of a performance-based approach to testing and improving readability called user testing. This method is now widely used to improve patient medicine leaflets - determining whether people can find and understand key facts. This study applied for the first time a controlled design to determine whether a PIS developed through user testing had improved readability over the original, using a sheet from a UK trial in acute myeloid leukemia (AML16).
Methods:
In the first phase the performance of the original PIS was tested on people in the target group for the trial. There were three rounds of testing including 50 people in total - with the information revised according to its performance after each of the first 2 rounds. In the second phase, the revised PIS was compared with the original in a parallel groups randomised controlled trial (RCT) A total of 123 participants were recruited and randomly allocated to read one version of the PIS to find and show understanding of 21 key facts.
Results:
The first, developmental phase produced a revised PIS significantly altered in its wording and layout. In the second, trial phase 66% of participants who read the revised PIS were able to show understanding of all aspects of the trial, compared with 15% of those reading the original version (Odds Ratio 11.2; Chi-square = 31.5 p < .001). When asked to state a preference, 87.1% participants chose the revised PIS (Sign test p < .001).
Conclusions:
The original PIS for the AML16 trial may not have enabled valid consent. Combining performance-based user testing with expertise in writing for patients and information design led to a significantly improved and preferred information sheet. User testing is an efficient method for indicating strengths and weaknesses in trial information, and Research Ethics Committees and Institutional Review Boards should consider requesting such testing, to ensure that PIS are fit-for-purpose